|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001492,
umls-concept:C0033572,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0058623,
umls-concept:C0078067,
umls-concept:C0086376,
umls-concept:C1123033,
umls-concept:C1280500,
umls-concept:C1555707,
umls-concept:C1704448,
umls-concept:C1705851,
umls-concept:C2752151,
umls-concept:C2828366
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-11-27
|
|
pubmed:abstractText |
Tadenan (a Pygeum africanum extract) is a drug used in the treatment of benign prostatic hyperplasia. Its effects on prostate fibroblast proliferation and bladder function after partial outlet obstruction have been demonstrated in various pharmacological studies. However, its effects at the molecular level are poorly documented.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0270-4137
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2000 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
245-52
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:11074527-Adenylate Cyclase,
pubmed-meshheading:11074527-Administration, Oral,
pubmed-meshheading:11074527-Animals,
pubmed-meshheading:11074527-Cell Division,
pubmed-meshheading:11074527-Fatty Alcohols,
pubmed-meshheading:11074527-GTP-Binding Proteins,
pubmed-meshheading:11074527-Growth Inhibitors,
pubmed-meshheading:11074527-Male,
pubmed-meshheading:11074527-Plant Extracts,
pubmed-meshheading:11074527-Prostate,
pubmed-meshheading:11074527-Rats,
pubmed-meshheading:11074527-Rats, Wistar,
pubmed-meshheading:11074527-Receptors, Vasoactive Intestinal Peptide
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Effects of Pygeum africanum extract (Tadenan) on vasoactive intestinal peptide receptors, G proteins, and adenylyl cyclase in rat ventral prostate.
|
|
pubmed:affiliation |
Unidad de Neuroendocrinología Molecular, Departamento de Bioquímica y Biología Molecular, Universidad de Alcalá, Alcalá de Henares, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
